?????????????????????????? ???????????????????????????????????????????????????? ???????????????????????????Unfit people also have the choice of venetoclax in addition obinutuzumab (VO) as frontline therapy. This is based over a phase III trial that as opposed VO with ClbO in elderly/unfit people.113 VO was excellent in terms of reaction price and d… Read More